Forward Pharma bags millions
Danish biotech Forward Pharma, in which major investor Florian Schönharting is Chairman of the board, has received a binding commitment for a massive capital injection. But what will the money be used on?
by Benjamin Werner Christensen
USD 11.3 million. That is how much money Forward Pharma's investors have commited to posting in the Danish biotech company, according to the recently published annual report. The money will allow Forward Pharma to further develop its activities, but the company does not reveal what exactly the money will go toward.
Allerede abonnent?Log ind her
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
Med din prøveperiode får du:
Få fuld adgang til dig og dine kollegaer
Start et gratis virksomhedsprøveabonnementRelaterede artikler
Forward Pharma self-assured in 'giant rivalry'
For abonnenter
Danish biotech company considers global partnership
For abonnenter
